Akanda Corp. (AKAN) vs Bone Biologics Corporation (BBLG)
A side-by-side comparison of Akanda Corp. and Bone Biologics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AKAN
Akanda Corp.
$1.88HealthcareDelayed quote: Oct 6, 2026, 3:44 PM EDT
BBLG
Bone Biologics Corporation
$0.47HealthcareDelayed quote: Oct 6, 2026, 3:39 PM EDT
Total return — AKAN vs BBLG
growth of $100 · dividends reinvested · last 5yAKAN -100.0% (-91.8%/yr)BBLG -100.0% (-79.4%/yr)BBLG compounded faster over this window
Log scale — wide-divergence pair
AKAN BBLG
AKAN vs BBLG: by the numbers
- •BBLG is the larger company ($850879 vs $60942 market cap).
- •Both run net losses; BBLG's is the smaller (0.00% vs -17690.19% net margin).
Metrics side by side
Valuation
| Metric | AKAN | BBLG |
|---|---|---|
| P/B ratio | N/A | 0.22 |
Profitability
| Metric | AKAN | BBLG |
|---|---|---|
| Gross margin | -60.46% | 0.00% |
| Operating margin | -1930.99% | 0.00% |
| Net margin | -17690.19% | 0.00% |
| ROE | N/A | -73.66% |
| ROIC | -242.09% | -78.01% |
Growth (annualized)
| Metric | AKAN | BBLG |
|---|---|---|
| Revenue CAGR (5Y) | 162.75% | N/A |
Go deeper
Dig into the metrics
Akanda ROEBone Biologics ROEAkanda operating marginBone Biologics operating marginAkanda revenue growthBone Biologics revenue growthAkanda free cash flowBone Biologics free cash flow
Akanda & Bone Biologics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.